Key result
Following anthracycline chemotherapy, significant longitudinal peak systolic strain reduction occurred in 32.4% of myocardial segments, occurring more frequently in basal segments.
Why the study?
Does 2D strain echocardiography detect segmental myocardial dysfunction in breast cancer patients undergoing anthracycline chemotherapy?
Observational (n=63)
No
Does 2D strain echocardiography detect segmental myocardial dysfunction in breast cancer patients undergoing anthracycline chemotherapy?
Segmental evaluation of longitudinal peak systolic strain by 2D echocardiography may detect early anthracycline-induced cardiotoxicity, particularly in basal segments, even when global strain is unchanged.
Answers are grounded in this paper and cite their sources.
Segmental LPSS monitoring may flag early anthracycline cardiotoxicity; leaves open prospective validation of basal predominance.
Introduction: Two-dimensional (2D) strain echocardiography has emerged as a novel method for early diagnosis of myocardial dysfunction in patients receiving anthracycline chemotherapy. Certain myocardial segments might be more vulnerable for development of dysfunction. Methods: Sixty-three patients with breast cancer who were deemed amenable for anthracycline chemotherapy were prospectively studied from March 2013 to March 2015 in University Hospital settings. Global left ventricular (LV) ejection fraction (EF), fractional shortening and the strain over 17 segments of the LV were examined using 2-dimensional transthoracic echocardiography (TTE) before and after chemotherapy. More than 15% reduction in longitudinal peak systolic strain (LPSS) was considered significant. Results: The mean age of patients was 47 ± 10 years. LVEF was 59.7 ± 6.5% at baseline. Significant reduction of global LPSS was detected in 13% of patients. A significant LPSS reduction occurred in 32.4% of 1071 segments examined following chemotherapy. LPSS significantly decreased in 28% of apical segments, 31% of mid segments and 37% of basal segments. LPSS reduction occurred more frequently over the basal segments than all other segments (P = 0.031). Conclusion: Segmental pattern appears to exist in LPSS reduction following anthracycline therapy. As significant segmental decreases can be seen in the setting of unchanged global LPSS, segmental evaluation of LPSS might be a more accurate way for assessment of myocardial function.
No takes yet. Share an insight, caveat, or question.
Toufan et al. (2017) conducted an observational in Breast cancer (n=63). Anthracycline chemotherapy vs. Baseline (pre-chemotherapy) was evaluated on Significant reduction (>15%) in longitudinal peak systolic strain (LPSS) across examined myocardial segments. Following anthracycline chemotherapy, significant longitudinal peak systolic strain reduction occurred in 32.4% of myocardial segments, occurring more frequently in basal segments.
Synapse has enriched 10 related papers. Consider them for comparative context: